Dr. Harvey Fineberg

President, Gordon and Betty Moore Foundation

Chair, National Academies Standing Committee on Emerging Infectious Diseases and 21st Century Health Threats


Harvey V. Fineberg is president of the Gordon and Betty Moore Foundation. He previously served as president of the U.S. Institute of Medicine (now National Academy of Medicine), as provost of Harvard University, and as dean of the Harvard Chan School of Public Health. Prior to joining a philanthropic foundation, he devoted most of his academic career to the fields of health policy and medical decision-making. His past research has focused on global health, assessment of medical technology, evaluation and use of vaccines, and dissemination of medical innovations.

Dr. Fineberg previously chaired the boards of the Carnegie Endowment for International Peace and the William and Flora Hewlett Foundation. He chairs the board of the Science Philanthropy Alliance, is a member of the China Medical Board, and served on the boards of the Josiah Macy, Jr. Foundation and the Association FXB (USA). He helped found and served as president of the Society for Medical Decision Making. Dr. Fineberg serves on the editorial board of the New England Journal of Medicine and in a number of advisory capacities, including the foresight committee of the Veolia Environment Institute and scientific advisory board of the Singapore National Research Foundation. He chairs the advisory board of the Peterson Center on Healthcare, co-chairs the inaugural international advisory board of Tsinghua University Vanke School of Public Health, and chairs the U.S. National Academies standing committee on emerging infectious diseases and 21st century health threats.        

Dr. Fineberg is co-author of the books Clinical Decision Analysis, Innovators in Physician Education, and The Epidemic That Never Was, an analysis of the controversial U.S. immunization program against swine flu in 1976. He has co-edited books on such diverse topics as AIDS prevention, vaccine safety, understanding risk in society, and global health and has authored numerous articles published in professional journals. Dr. Fineberg is the recipient of several honorary degrees, the Frank A. Calderone Prize in Public Health, the Henry G. Friesen International Prize in Health Research, and the Harvard Medal, awarded by the alumni association of the university from which he earned his bachelor’s and doctoral degrees.

Dr. Harvey Fineberg

Speaker Session

Speaker Sessions

Day 2
9:15 AM EST

Keynote: Dr. Harvey Fineberg, President, Gordon and Betty Moore Foundation; Chair, National Academies Standing Committee on Emerging Infectious Diseases and 21st Century Health Threats

Hear reflections from the health expert tapped to lead the U.S. emergency committee that distilled the emerging science on COVID-19 to help inform policymakers.

Day 2
9:25 AM EST

Session VI: Implications – Science Advising: Achievements, Mistakes, & Lacunae So Far

We learned more about COVID-19 as the pandemic accelerated—how the virus is transmitted, the best ways to treat it, and how to stop its spread. Health advisors from the United States, Korea, China, and Nigeria discuss what we got right and where science advisors can do better in the future.